NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 309 filers reported holding NOVOCURE LTD in Q1 2022. The put-call ratio across all filers is 1.53 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,732,128 | -89.7% | 169,172 | -73.6% | 0.00% | -82.4% |
| Q2 2023 | $26,632,004 | -22.7% | 641,735 | +12.0% | 0.02% | -29.2% |
| Q1 2023 | $34,444,283 | +81.0% | 572,735 | +120.8% | 0.02% | +60.0% |
| Q4 2022 | $19,027,136 | -12.5% | 259,402 | -9.3% | 0.02% | -6.2% |
| Q3 2022 | $21,737,000 | +35.5% | 286,097 | +23.9% | 0.02% | +33.3% |
| Q2 2022 | $16,044,000 | -16.6% | 230,838 | -0.6% | 0.01% | 0.0% |
| Q1 2022 | $19,235,000 | -60.2% | 232,154 | -63.9% | 0.01% | -53.8% |
| Q4 2021 | $48,333,000 | -14.7% | 643,765 | +32.0% | 0.03% | -23.5% |
| Q3 2021 | $56,663,000 | -42.4% | 487,759 | +10.0% | 0.03% | -42.4% |
| Q2 2021 | $98,328,000 | +800.2% | 443,279 | +436.4% | 0.06% | +742.9% |
| Q1 2021 | $10,923,000 | -54.1% | 82,632 | -39.9% | 0.01% | -50.0% |
| Q4 2020 | $23,773,000 | +236.1% | 137,385 | +116.2% | 0.01% | +180.0% |
| Q3 2020 | $7,074,000 | +206.6% | 63,544 | +63.3% | 0.01% | +150.0% |
| Q2 2020 | $2,307,000 | -61.9% | 38,911 | -56.7% | 0.00% | -60.0% |
| Q1 2020 | $6,048,000 | +130.4% | 89,814 | +188.3% | 0.01% | +150.0% |
| Q4 2019 | $2,625,000 | -47.4% | 31,152 | -53.3% | 0.00% | -50.0% |
| Q3 2019 | $4,993,000 | +110.6% | 66,772 | +78.1% | 0.00% | +100.0% |
| Q2 2019 | $2,371,000 | +201.7% | 37,498 | +129.8% | 0.00% | +100.0% |
| Q1 2019 | $786,000 | +53.2% | 16,318 | +6.5% | 0.00% | 0.0% |
| Q4 2018 | $513,000 | +18.2% | 15,329 | +85.0% | 0.00% | – |
| Q3 2018 | $434,000 | +63.8% | 8,284 | -2.1% | 0.00% | – |
| Q2 2018 | $265,000 | +3685.7% | 8,458 | +2700.7% | 0.00% | – |
| Q1 2018 | $7,000 | -95.9% | 302 | -96.5% | 0.00% | – |
| Q4 2017 | $172,000 | -28.3% | 8,529 | -29.4% | 0.00% | – |
| Q3 2017 | $240,000 | +2566.7% | 12,080 | +2116.5% | 0.00% | – |
| Q2 2017 | $9,000 | -85.5% | 545 | -92.9% | 0.00% | – |
| Q1 2017 | $62,000 | -86.1% | 7,657 | -86.5% | 0.00% | – |
| Q4 2016 | $446,000 | +848.9% | 56,838 | +945.8% | 0.00% | – |
| Q3 2016 | $47,000 | +17.5% | 5,435 | +58.7% | 0.00% | – |
| Q2 2016 | $40,000 | -60.4% | 3,424 | -51.0% | 0.00% | – |
| Q1 2016 | $101,000 | +77.2% | 6,984 | +173.9% | 0.00% | – |
| Q4 2015 | $57,000 | – | 2,550 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 470,884 | $27,923,000 | 10.09% |
| Darsana Capital Partners LP | 1,700,000 | $100,810,000 | 5.98% |
| HARTLINE INVESTMENT CORP/ | 336,617 | $19,961,000 | 4.18% |
| Rhenman & Partners Asset Management AB | 375,000 | $22,238,000 | 2.40% |
| MORGAN JESS S & CO INC | 35,942 | $2,131,000 | 2.31% |
| Soleus Capital Management, L.P. | 56,397 | $3,344,000 | 1.91% |
| Bullseye Asset Management LLC | 45,161 | $2,678,000 | 1.43% |
| Taylor Frigon Capital Management LLC | 46,304 | $2,746,000 | 1.36% |
| COURAGE CAPITAL MANAGEMENT LLC | 10,000 | $593,000 | 1.09% |
| Redwood Investments, LLC | 192,986 | $11,444,000 | 1.01% |